title: Low PIAS3 expression in malignant mesothelioma is associated with increased STAT3 activation and poor patient survival.
abstract: OBJECTIVE
  Deregulation of STAT3 activation is a hallmark of many cancer cells, and the underlying mechanisms are subject to intense investigation. We examined the extent of PIAS3 expression in mesothelioma cells and human tumor samples and determined the functional effects of PIAS3 expression on STAT3 signaling.
  
  
  METHODS
  We evaluated the expression of PIAS3 in mesothelioma tumors from patients and correlated the expression levels with the course of the disease. We also measured the effects of enhanced PIAS3 activity on STAT3 signaling, cellular growth, and viability in cultured mesothelioma cells.
  
  
  RESULTS
  Gene expression databases revealed that mesotheliomas have the lowest levels of PIAS3 transcripts among solid tumors. PIAS3 expression in human mesothelioma tumors is significantly correlated with overall survival intervals (P = 0.058). The high expression of PIAS3 is predictive of a favorable prognosis and decreases the probability of death within one year after diagnosis by 44%. PIAS3 expression is functionally linked to STAT3 activation in mesothelioma cell lines. STAT3 downregulation with siRNA or enhanced expression of PIAS3 both inhibited mesothelioma cell growth and induced apoptosis. Mesothelioma cells are sensitive to curcumin and respond by the induction of PIAS3. Corroborative evidence has been obtained from STAT3 inhibition experiments. Exposure of the cells to a peptide derived from the PIAS3 protein that interferes with STAT3 function resulted in apoptosis induction and the inhibition of cell growth.
  
  
  CONCLUSIONS
  These results suggest that PIAS3 protein expression impacts survival in patients with mesothelioma and that PIAS3 activation could become a therapeutic strategy. Clin Cancer Res; 20(19); 5124-32. ©2014 AACR.
authors.affiliation: Division of Hematology and Oncology, Case Comprehensive Cancer Center and University Hospitals Case Medical Center, Cleveland, Ohio.
authors.forename: Snehal
authors.initials: S
authors.lastname: Dabir
authors.affiliation: Division of Hematology and Oncology, Case Comprehensive Cancer Center and University Hospitals Case Medical Center, Cleveland, Ohio.
authors.forename: Amy
authors.initials: A
authors.lastname: Kluge
authors.affiliation: Division of Pathology, Case Comprehensive Cancer Center and University Hospitals Case Medical Center, Cleveland, Ohio.
authors.forename: Adam
authors.initials: A
authors.lastname: Kresak
authors.affiliation: Division of Pathology, Case Comprehensive Cancer Center and University Hospitals Case Medical Center, Cleveland, Ohio.
authors.forename: Michael
authors.initials: M
authors.lastname: Yang
authors.affiliation: Division of Biostatistics, Case Comprehensive Cancer Center and University Hospitals Case Medical Center, Cleveland, Ohio.
authors.forename: Pingfu
authors.initials: P
authors.lastname: Fu
authors.affiliation: Institute for Biomedical Research, Georg-Speyer-Haus, Frankfurt, Germany.
authors.forename: Bernd
authors.initials: B
authors.lastname: Groner
authors.affiliation: Division of Hematology and Oncology, Case Comprehensive Cancer Center and University Hospitals Case Medical Center, Cleveland, Ohio.
authors.forename: Gary
authors.initials: G
authors.lastname: Wildey
authors.affiliation: Division of Hematology and Oncology, Case Comprehensive Cancer Center and University Hospitals Case Medical Center, Cleveland, Ohio. afshin.dowlati@case.edu.
authors.forename: Afshin
authors.initials: A
authors.lastname: Dowlati
mesh_terms: D017209:Apoptosis / Q000187:drug effects / Q000235:genetics; D045744:Cell Line, Tumor; D049109:Cell Proliferation / Q000187:drug effects; D003474:Curcumin / Q000494:pharmacology; D015870:Gene Expression; D006801:Humans; D008175:Lung Neoplasms / Q000235:genetics* / Q000378:metabolism* / Q000401:mortality; D008654:Mesothelioma / Q000235:genetics* / Q000378:metabolism* / Q000401:mortality; D000086002:Mesothelioma, Malignant; D018832:Molecular Chaperones / Q000737:chemistry / Q000235:genetics* / Q000378:metabolism / Q000494:pharmacology; D010446:Peptide Fragments / Q000494:pharmacology; D011379:Prognosis; D050828:Protein Inhibitors of Activated STAT / Q000737:chemistry / Q000235:genetics* / Q000378:metabolism / Q000494:pharmacology; D034622:RNA Interference; D012333:RNA, Messenger / Q000235:genetics; D034741:RNA, Small Interfering / Q000235:genetics; D050796:STAT3 Transcription Factor / Q000235:genetics / Q000378:metabolism*
chemical_list: D018832:Molecular Chaperones; C484745:PIAS3 protein, human; D010446:Peptide Fragments; D050828:Protein Inhibitors of Activated STAT; D012333:RNA, Messenger; D034741:RNA, Small Interfering; D050796:STAT3 Transcription Factor; D003474:Curcumin